NCT04496037View on ClinicalTrials.gov

Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant

Not yet recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

July 1, 2027

Study Completion Date

August 31, 2028

Conditions
Transplant; Complication, Rejection
Interventions
DRUG

Rituximab

See NCT03994783

All Listed Sponsors
collaborator

University of Cambridge

OTHER

collaborator

Viapath LLP

UNKNOWN

lead

Imperial College London

OTHER

NCT04496037 - Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant | Biotech Hunter | Biotech Hunter